BARD1 and breast cancer: One patient who suffered from ovarian cancer and breast cancer with therapy-related MDS (t-MDS) had germline mutations in BARD1 and MUTYH. The patient was first diagnosed with ovarian cancer at the age of 75, which is compatible with the moderate penetrance that the putative disease-causing gene has.